MEDGENICS INC WT PUR COM EXP 03/31/16
MDGN.WS
MDGN.WS was delisted on the 7th of April, 2016.
0 hedge funds and large institutions have $0 invested in MEDGENICS INC WT PUR COM EXP 03/31/16 in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.17M → $0 (-$1.17M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.17M |
MDGN.WS Hedge Fund Activity: Q2 2016 in Review
0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) for Q2 2016, worth a combined $0 — down 100% from $1.17M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MDGN.WS and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $1.17M sold.
- 0 institutional investors held MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) as of Q2 2016, down from 2 in Q1 2016.
- Funds reported $0 of MEDGENICS INC WT PUR COM EXP 03/31/16 stock for Q2 2016, down 100% quarter-over-quarter.
- 0 funds opened new MEDGENICS INC WT PUR COM EXP 03/31/16 positions in Q2 2016 and 2 closed out, a net change of -2 holders.
- The largest MEDGENICS INC WT PUR COM EXP 03/31/16 seller in Q2 2016 was Sabby Management, an estimated $1.17M sold.
Based on aggregated 13F filings for Q2 2016.